In addition, our findings suggest that EMX2 functions as a key regulator of tumor stemness in a specific part and chemotherapeutic sensitivity, with high EMX2 expression correlating with increased colony formation capacity in vitro, tumor formation capacity in vivo, and reduced sensitivity to 5-FU treatment. Here, EMX2 is linked to neoplasm.